Regencell Bioscience Holdings Limited (RGC) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2023 - CSIMarket
CSIMarket
 


Regencell Bioscience Holdings Limited  (NASDAQ: RGC)


Regencell Bioscience Holdings Limited's ROI from its fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Regencell Bioscience Holdings Limited's ROI in the fourth quarter of 2025?
Regencell Bioscience Holdings Limited recorded a cumulative net loss of $-4 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -70.39%.

Within the Consumer Non Cyclical sector 150 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 4011.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2023)
IV. Quarter
Y / Y Investment Change TTM -53.86 % -50.95 % -43.09 % -36.7 % -31.4 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 5 5 5 5 8
Return On Investment (TTM) -70.39 % -103.21 % -79.83 % -65.08 % -54.94 %
RGC's Overall Ranking # 4011 # # # #
Seq. Investment Change TTM -13.31 % -22.66 % -18.47 % -15.59 % -7.84 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -4 -6 -6 -6 -6




Return On Investment RGC's Ranking
Within: No.
Industry # 18
Sector # 151
Overall # 4011

Return On Investment Statistics
High Average Low
2.66 %
-7.37 %
-70.39 %
(Dec 31 2015)   (Jun 30 2025)







Financial Statements
Regencell Bioscience Holdings Limited's IV. Quarter Investments $ 5 Millions RGC's Balance sheet
Regencell Bioscience Holdings Limited's IV. Quarter Income $ -4 Millions Quarterly RGC's Income Statement
RGC's Income by Division See RGC's Income by Division


RGC Annual Return On Investment (Jun 30 2025)
2025
(Jun 30 2024)
2024
(Jun 30 2023)
2023
(Jun 30 2022)
2022
(Jun 30 2021)
2021
Total Investments in Millions 5 8 12 17 -4
Y / Y Investment Growth -38.05 % -31.36 % -31.41 % - -
Net Income in Millions -4 -4 -6 -8 -1
Y / Y Net Income Growth - - - - -
Annual Return On Investment -70.39 % -53.09 % -50.63 % -43.51 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Legal Cannabis Industry Roi Trends and Statistics
Consumer Non Cyclical Sector Return On Investment Statistics
Roi Trends for overall market
RGC's Roi Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RGC's Competitors
Subscribers only: Roi for Regencell Bioscience Holdings Limited's Suppliers
Subscribers only: Return On Investment for RGC's Customers

Other Ratios
RGC's Roa RGC's Inventory Turnover Ratio RGC's Growth Rates RGC's Dividend Statistics
RGC's Profitability Ratios RGC's Asset Turnover Ratio RGC's Dividend Growth
RGC's Roe RGC's Valuation Ratios RGC's Financial Strength Ratios RGC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Consumer Non Cyclical Sector ROI


Date modified: 2026-07-07T13:05:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.